Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15 | Zendy

AI Assistant Blog Pricing

Prospective phase II study of preemptive chimerism-driven reduction of immunosuppression after non-myeloablative conditioning—Eudract #: 2007-002420-15

Details

The content you want is available to Zendy users.Already have an account? Click here. to sign in.